Board MeetingMay 4, 2026, 07:32 AM
Vera Therapeutics to Present at Bank of America Health Care Conference
AI Summary
Vera Therapeutics, Inc. announced that its management team will present at the Bank of America Securities 2026 Health Care Conference on May 13, 2026, at 4:20 PM PDT. The team will also hold one-on-one investor meetings. The company is focused on developing treatments for serious immunological diseases, with lead product candidate atacicept for IgA nephropathy and lupus nephritis, and other candidates VT-109 and MAU868 in its pipeline.
Key Highlights
- Vera Therapeutics management to present at Bank of America Securities 2026 Health Care Conference.
- Presentation scheduled for Wednesday, May 13, 2026, at 4:20 PM PDT.
- Management will also participate in one-on-one investor meetings.
- A webcast of the presentation will be available at https://bofa.veracast.com/webcasts/bofa/healthcare2026/24Ty86.cfm.
- A replay will be available for 90 days on the company's website.
- Vera Therapeutics focuses on treatments for serious immunological diseases.
- Lead product candidate is atacicept, targeting IgA nephropathy (IgAN) and lupus nephritis.
- Company is also developing VT-109 and MAU868 for B-cell mediated diseases and BK virus infection.
Price Impact
More from VERA